PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.280
-0.020 (-1.54%)
Apr 7, 2026, 1:14 PM EDT - Market open
PMV Pharmaceuticals Market Cap
PMV Pharmaceuticals has a market cap or net worth of $68.26 million as of April 7, 2026. Its market cap has increased by 4.32% in one year.
Market Cap
68.26M
Enterprise Value
-42.78M
1-Year Change
4.32%
Ranking
Category
Stock Price
$1.28
Market Cap Chart
Since the IPO on September 25, 2020, PMV Pharmaceuticals's market cap has decreased from $1.61B to $68.26M, a decrease of -95.77%. That is a compound annual growth rate of -43.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 6, 2026 | 69.33M | 4.23% |
| Dec 31, 2025 | 66.51M | -14.88% |
| Dec 31, 2024 | 78.14M | -50.73% |
| Dec 29, 2023 | 158.59M | -60.08% |
| Dec 30, 2022 | 397.29M | -62.10% |
| Dec 31, 2021 | 1.05B | -61.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Coeptis Therapeutics Holdings | 74.55M |
| eXoZymes | 74.11M |
| NRx Pharmaceuticals | 72.68M |
| Fractyl Health | 72.33M |
| XBiotech | 71.65M |
| Cingulate | 71.40M |
| BeyondSpring | 70.93M |
| MediciNova | 70.88M |